YTL:MYXYTL Corp Bhd. Analysis
Data as of 2026-06-11 - not real-time
$0.52
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
YTL Corp's share price sits at $0.5233, well below its DCF-derived fair value of $1.77, indicating a sizable discount. The stock trades beneath its 20‑day (0.48) and 50‑day (0.43) moving averages, though it remains under the 200‑day SMA (0.56), suggesting a neutral longer‑term trend. Momentum signals are mixed: RSI at 67 points to near‑overbought conditions, while the MACD line sits just above its signal, offering a modest bullish tilt. Volume has been on a downward trajectory, and 30‑day volatility exceeds 100%, highlighting short‑term price instability. Fundamental metrics reinforce the discount: a trailing PE of 17.4 is below the sector average of 20.4, and the price‑to‑book of 1.42 reflects modest valuation. However, free cash flow is negative (‑$3.99 bn) and debt‑to‑equity is extremely high at 188%, raising concerns about financial flexibility.
The company still delivers a 2.26% dividend yield with a payout ratio of 37%, which is sustainable only if cash generation improves. YTL’s diversified utilities and infrastructure portfolio provides defensive characteristics typical of the sector. Regulatory exposure is moderate, while geographic concentration in Malaysia adds a medium‑level country risk. Given the deep valuation gap and attractive yield, the stock appears undervalued for medium‑term investors. Nonetheless, the high leverage and volatile price action counsel caution for short‑term traders. Overall, a balanced approach—holding for the near term while positioning for a buy on the medium horizon is prudent.
The company still delivers a 2.26% dividend yield with a payout ratio of 37%, which is sustainable only if cash generation improves. YTL’s diversified utilities and infrastructure portfolio provides defensive characteristics typical of the sector. Regulatory exposure is moderate, while geographic concentration in Malaysia adds a medium‑level country risk. Given the deep valuation gap and attractive yield, the stock appears undervalued for medium‑term investors. Nonetheless, the high leverage and volatile price action counsel caution for short‑term traders. Overall, a balanced approach—holding for the near term while positioning for a buy on the medium horizon is prudent.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI approaching overbought territory
- Decreasing trading volume
- Recent quarter profit decline
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant discount to DCF fair value
- Dividend yield above 2% with moderate payout
- PE below industry average
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Diversified utilities and infrastructure assets
- High leverage and negative free cash flow
- Regulatory and geographic exposure
Key Metrics & Analysis
Financial Health
Revenue Growth3.40%
Profit Margin5.64%
P/E Ratio17.4
ROE12.21%
ROA3.95%
Debt/Equity187.80
P/B Ratio1.4
Op. Cash Flow$5.4B
Free Cash Flow$-3992393984
Industry P/E20.4
Technical Analysis
TrendNeutral
RSI67.4
Support$0.39
Resistance$0.56
MA 20$0.48
MA 50$0.43
MA 200$0.56
MACDBullish
VolumeDecreasing
Fear & Greed Index83.13
Valuation
Fair Value$1.77
GradeUndervalued
TypeValue
Dividend Yield2.26%
Risk Assessment
Beta0.10
Volatility106.13%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.